ArticleFrontiers in immunology2026
Integrated single-cell and experimental analyses implicate GPRC5B in macrophage senescence-related alterations in postmenopausal osteoporosis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-menopausal osteoporosis (PMO) is characterized by senescence, estrogen deficiency, immune dysregulation and progressive bone loss, yet the molecular alterations involved in PMO remain incompletely understood. Methods: Single-cell and transcriptomic analyses were integrated with machine learning and experimental validation. Ovariectomized mouse models, primary bone marrow-derived macrophages and RAW264.7 cells were used to evaluate gene expression, senescence-associated changes, macrophage polarization and related signaling pathways. Results: Single-cell RNA sequencing revealed substantial remodeling of the bone marrow microenvironment in PMO and identified APOE-positive macrophages as a dominant subset with elevated KRAS-related signaling. Integrated co-expression and machine-learning analyses yielded GPRC5B as a PMO-associated candidate gene that was consistently upregulated across multiple datasets. Conclusions: GPRC5B is a macrophage-enriched, PMO-associated candidate identified through integrated transcriptomic analyses and supported by preliminary functional experiments. These findings suggest that GPRC5B may participate in macrophage-related alterations in PMO and warrant further mechanistic and translational investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.